Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GH and IGF-I combination therapy in growth hormone-deficient adults with impaired glucose tolerance or diabetes
2009-011534-10Phase 2Completed
- Sponsor
- Karolinska University Hospital
- Start
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of somatropin and mecasermin in growth hormone deficiency (GHD), prediabetes and diabetes mellitus (DM), sponsored by Karolinska University Hospital. Primary endpoint: Insulin sensitivity evaluated with hyperinsulinemic euglycemic clamp. Started Apr 2009; status: completed.
02
Drugs
somatropinmecasermin
03
Conditions
growth hormone deficiency (GHD)prediabetesdiabetes mellitus (DM)
Beyond the preview
Go deeper on 2009-011534-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011534-10.